Equities research analysts expect Cavium, Inc. (NASDAQ:CAVM) to announce earnings of $0.81 per share for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Cavium’s earnings. The lowest EPS estimate is $0.79 and the highest is $0.81. Cavium posted earnings per share of $0.56 in the same quarter last year, which indicates a positive year-over-year growth rate of 44.6%. The business is expected to announce its next quarterly earnings report on Wednesday, February 7th.

On average, analysts expect that Cavium will report full-year earnings of $2.82 per share for the current year, with EPS estimates ranging from $2.79 to $2.82. For the next financial year, analysts forecast that the business will report earnings of $3.57 per share, with EPS estimates ranging from $3.40 to $3.67. Zacks’ earnings per share averages are an average based on a survey of research firms that follow Cavium.

Cavium (NASDAQ:CAVM) last released its quarterly earnings results on Wednesday, November 1st. The semiconductor provider reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.74 by $0.02. The business had revenue of $251.99 million during the quarter, compared to the consensus estimate of $250.16 million. Cavium had a positive return on equity of 11.16% and a negative net margin of 19.94%. The company’s quarterly revenue was up 49.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.43 EPS.

A number of equities analysts have issued reports on the company. Jefferies Group downgraded Cavium from a “buy” rating to a “hold” rating in a research note on Tuesday, November 21st. Loop Capital reiterated a “buy” rating and set a $81.00 price target on shares of Cavium in a research note on Tuesday, August 22nd. Canaccord Genuity lifted their price target on Cavium from $66.00 to $67.00 and gave the company a “hold” rating in a research note on Thursday, November 2nd. BidaskClub downgraded Cavium from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Finally, Morgan Stanley cut their target price on Cavium from $78.00 to $77.00 and set an “overweight” rating on the stock in a research note on Thursday, November 2nd. Eleven analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $78.41.

Cavium (NASDAQ CAVM) opened at $84.01 on Friday. The stock has a market capitalization of $5,854.03, a PE ratio of 78.38, a price-to-earnings-growth ratio of 3.40 and a beta of 1.36. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.27 and a current ratio of 2.87. Cavium has a 12 month low of $56.96 and a 12 month high of $88.96.

In related news, VP Anil Kumar Jain sold 8,500 shares of Cavium stock in a transaction that occurred on Tuesday, November 21st. The shares were sold at an average price of $85.90, for a total value of $730,150.00. Following the sale, the vice president now owns 91,616 shares of the company’s stock, valued at approximately $7,869,814.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Vincent P. Pangrazio sold 15,000 shares of Cavium stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $77.22, for a total transaction of $1,158,300.00. Following the completion of the sale, the senior vice president now directly owns 60,039 shares in the company, valued at approximately $4,636,211.58. The disclosure for this sale can be found here. 4.65% of the stock is owned by insiders.

Several large investors have recently bought and sold shares of CAVM. Ameriprise Financial Inc. raised its holdings in shares of Cavium by 42.9% in the 3rd quarter. Ameriprise Financial Inc. now owns 3,425,325 shares of the semiconductor provider’s stock worth $225,867,000 after purchasing an additional 1,027,760 shares during the period. Frontier Capital Management Co. LLC raised its holdings in shares of Cavium by 581.0% in the 3rd quarter. Frontier Capital Management Co. LLC now owns 820,499 shares of the semiconductor provider’s stock worth $54,104,000 after purchasing an additional 700,015 shares during the period. Jennison Associates LLC raised its holdings in shares of Cavium by 50.6% in the 3rd quarter. Jennison Associates LLC now owns 1,939,958 shares of the semiconductor provider’s stock worth $127,921,000 after purchasing an additional 652,177 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Cavium by 16.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,353,670 shares of the semiconductor provider’s stock worth $217,753,000 after purchasing an additional 478,019 shares during the period. Finally, Bank of New York Mellon Corp raised its holdings in shares of Cavium by 164.3% in the 3rd quarter. Bank of New York Mellon Corp now owns 661,218 shares of the semiconductor provider’s stock worth $43,601,000 after purchasing an additional 411,033 shares during the period.

TRADEMARK VIOLATION WARNING: This piece of content was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/15/cavium-inc-cavm-expected-to-announce-earnings-of-0-81-per-share.html.

Cavium Company Profile

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

Get a free copy of the Zacks research report on Cavium (CAVM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cavium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium and related companies with MarketBeat.com's FREE daily email newsletter.